Presentation to the IBEC R&D Funding and Tax Symposium IDA Strategy for RD&I Brendan McDonagh Gus Jones 6 t

1. Presentation to the IBEC R&D Fundingand Tax SymposiumIDA Strategy for RD&IBrendan McDonagh Gus Jones6th July 2011

2. IDA Focus Business Models • Research, Development & Innovation • High value/high technology Manufacturing • Global Services Sectors • Life Sciences – Pharma/Bio/Medical Devices • Information & Communications Technology • Financial Services • CCBS – Consumer Brands, Professional Services, Digital Media, • Clean Tech – Environment, Green Products/Services • Engineering & Diversified Services

3. IDA RD&I Strategy • Leverage State’s investment to encourage, support, drive and capture RD&I from MNCs • Generate and implement initiatives that build an applied research capability • Foster an environment of ‘collaboration’ between business, academia & Government • Ensure RD&I policies are business friendly

4. RD&I Supports • Training & Feasibility • RD&I Support Grant • R&D Tax Credit • 25% tax credit on R&D activities • Intellectual Property tax exemptions • Exemption from stamp duty on transfer of IP • Tax exemption on income earned from royalties on qualifying Irish patents

5. Training & Feasibility Support • Support for first time RD&I activity • Feasibility Study • Training support • Pilot RD&I project • Maximum Grant available €250K • Grant range 25% to 50% depending on nature and purpose of activities

6. RD&I Support Grant 4 Models Standalone Company establishes a unique centre to support either corporate research or an innovation agenda through a standalone facility in Ireland Collaborative RD&I project that is dependent on a substantial engagement with an Irish academic institution Development & Manufacturing or Services Delivery RD&I process or product development to reduce costs and increase quality and output Development & Commercialisation RD&I investment whose outputs will be commercialised and delivered from Ireland

7. Evaluation of RD&I Proposals • Overall objective is to support new andincrementalinvestment • Evaluated on: • Commercial benefits • Economic benefits • Technical complexity & innovation • Grant rate dependent on evaluation • Value for the State’s money

8. Benefits to MNCs of Irish RD&I Investment • Sustains existing operations and jobs in Ireland • Adds new high level business function(s) • Creates highly skilled R&D centres • Enhances capabilities of existing operations • heightens the profile of the Irish subsidiary with its parent • helps position Irish company for additional investment from parent

9. Engineering related Competence Centres Bioenergy & Biorefining Manufacturing Research (NUIG) Energy Efficiency in Manufacturing IT Innovation (NUI Maynooth) Composite Research (UL) (Tyndall UCC) Microelectronics (UL)

10. Other Research Supports The National Institute for Bioprocessing Research and Training (NIBRT) The National Institute for Bioprocessing Research and Training (NIBRT) is a world-class institute that provides training and research solutions for the bioprocessing industry in state of the art facilities.  NIBRT is located in Dublin, Ireland and is based on an innovative collaboration between University College Dublin, Trinity College Dublin,Dublin City University and Institute of Technology Sligo. International Energy Research Centre

11. Other RD&I Supports • IDA/EI Competence Centre programme • Enterprise Ireland’s Innovation Partnership Programme • SFI CSET, SRC, Industrial Supplements • EU Framework 7

12. FURTHER INFORMATION FOR FURTHER INFORMATION PLEASE CONTACT YOUR PROJECT EXECUTIVE OR GO TO: WWW.IDAIRELAND.COM